UNSPSC 51161812: Combination chlorpheniramine acetaminophen

This classification denotes a combination cough and cold and antiallergy drug. The first component of this drug is a histamine-1 receptor antagonist with the molecular formula C16H19ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3U6IO1965U, chemically known as 3-(p-chlorophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but generally known as chlorphenamine, which bears US NIH Compound Identifier 2725.

UNSPSC 51161812 Combination chlorpheniramine acetaminophen is a Commodity code that in recent state and local procurement activity covers naloxone and drug deactivation systems, as well as generic multi-source pharmaceuticals and over-the-counter products supplied through authorized wholesale distributors to government health facilities. State and local issuing bodies soliciting under this code include county health departments and multistate cooperative purchasing alliances administering pharmaceutical procurement on behalf of participating state agencies and local government facilities. The scope extends beyond the code's nominal name to encompass emergency-response pharmaceuticals and broad OTC product lines distributed through established pharmaceutical supply chains.

Geographic activity centers on Florida and the Upper Midwest, with multistate cooperative vehicles expanding reach across participating jurisdictions including Oregon. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a proposal deadline of March 26, 2026. The MMCAP procurement requires cGMP certification and Drug Supply Chain Security Act compliance, pricing submission through authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, and carries a 3 percent administrative fee on all contract purchases. Vendors must maintain substantial insurance coverage and demonstrate pricing flexibility across multiple formats, with contract terms of two years for new responders and optional extensions at MMCAP's discretion.